Natrium-Hydrogen-Carbonicum Pharmamagist (Sodium Hydrogen Carbonate)

Sodium Hydrogen Carbonate, the active ingredient in Natrium-Hydrogen-Carbonicum Pharmamagist, is a Excipient presented as a pharmaceutical grade powder for Intravenous, Subcutaneous use. It functions as a buffering and alkalinising agent in clinical preparations. GNH USA supplies Natrium-Hydrogen-Carbonicum Pharmamagist as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Sodium Hydrogen Carbonate is employed as an alkalinising and buffering agent in several clinical contexts. - Metabolic acidosis: helps correct systemic acid‑base imbalance by increasing plasma bicarbonate levels. - Hyperkalemia: promotes intracellular shift of potassium, aiding in temporary reduction of serum potassium. - Urinary alkalinisation: facilitates excretion of certain drugs and toxins by raising urinary pH. - Injectable solution preparation: serves as a solvent and pH stabiliser for various IV and subcutaneous formulations.

Sodium Hydrogen Carbonate may cause a range of adverse reactions depending on dose and patient condition. Common Side Effects: - Metabolic alkalosis: elevated blood pH leading to dizziness or fatigue. - Hypernatremia: increased serum sodium causing thirst or edema. - Hypokalemia: lowered potassium levels resulting in muscle weakness. - Fluid overload: excess volume leading to peripheral edema. - Nausea or mild gastrointestinal discomfort. Serious or Rare Side Effects: - Severe metabolic alkalosis with respiratory depression. - Paradoxical intracellular acidosis. - Cardiac arrhythmias due to electrolyte shifts. - Pulmonary edema in patients with compromised cardiac function. - Seizures secondary to extreme alkalosis.

When using Sodium Hydrogen Carbonate, clinicians should observe several safety measures. - Assess acid‑base status: verify baseline pH and bicarbonate before initiation. - Monitor electrolytes: regularly check serum sodium, potassium, and chloride. - Adjust dose in renal impairment: reduced clearance may increase risk of alkalosis. - Use cautiously in heart failure or hypertension: fluid and sodium load can exacerbate conditions. - Avoid in severe hypernatremia: further sodium increase may be harmful. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Sodium Hydrogen Carbonate can influence the pharmacokinetics or safety of several agents. Major Interactions (Avoid): - Concomitant use with potassium‑sparing diuretics: risk of hyperkalemia. - Co‑administration with calcium carbonate: may cause excessive alkalosis. - Interaction with certain antibiotics (e.g., tetracyclines): reduced absorption due to increased gastric pH. Moderate Interactions (Monitor Closely): - Use with anticoagulants (e.g., warfarin): altered plasma protein binding may affect INR. - Combination with loop diuretics: enhanced loss of potassium and magnesium. - Concurrent administration of insulin: may potentiate intracellular potassium shift.